Drug Markets/Epoetin Alfa

Epoetin Alfa

4 NDCs across 1 manufacturer|0 Generic,4 Brand

Epoetin Alfa is used to treat anemia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $166 million on Epoetin Alfa across 123,000 claims for 29,000 beneficiaries.

Epoetin Alfa is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $32.27 to $320.15 per ML — the most expensive product costs about 9.9× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

0G / 4B

Manufacturers

1

competing in market

Price Spread

$32.27 – $320.15

per ML

7d Activity

1↓3 flat

avg -0.0% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing EPOETIN ALFA

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Epoetin Alfa used to treat?

Epoetin Alfa is used to treat anemia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Epoetin Alfa?

In 2024, Medicare Part D spent $166 million on Epoetin Alfa across 123,000 claims for 29,000 beneficiaries.

How many Epoetin Alfa products are on the market?

The Epoetin Alfa drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.

What is the price range for Epoetin Alfa?

NADAC reference prices for Epoetin Alfa range from $32.2669 to $320.1466 per ML — the most expensive product costs about 9.9× the cheapest.

Which manufacturers make Epoetin Alfa?

1 manufacturer lists Epoetin Alfa in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (4).

How has the price of Epoetin Alfa changed recently?

Over the past 7 days, 0 Epoetin Alfa NDCs rose and 1 fell, with a market-wide average change of -0.0%.